34699
Federal Register / Vol. 66, No. 126 / Friday, June 29, 2001 / Notices
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Dated: June 22, 2001.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 01–16334 Filed 6–28–01; 8:45 am]
BILLING CODE 4140–01–M
National Heart, Lung, and Blood
Institute; Notice of Closed Meeting
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Heart, Lung, and Blood
Institute; Notice of Closed Meeting
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The contract proposals and
the discussions could disclose
confidential trade secrets or commercial
property such a patentable material, and
personal information concerning
individuals associated with the contract
proposals, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Heart, Lung,
and Blood Institute Special Emphasis Panel,
Gene Transfer for Heart, Lung, and Blood
Diseases.
Date: July 18, 2001.
Time: 1:30 pm to 2:30 pm.
Agenda: To review and evaluate grant
applications.
Place: 6701 Rockledge Drive, Bethesda, MD
20892, (Telephone Conference Call).
Contact Person: Anne P Clark, NIH,
NHLBI, DEA, Review Branch, Rockledge II,
6701 Rockledge Drive, Room 7202, Bethesda,
MD 20892–7924, 301/435–0310.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Heart, Lung,
and Blood Institute Special Emphasis Panel,
The Framingham Heart Study RFP–NHLBI–
HC–01–02.
Date: July 10, 2001.
Time: 9 am to 11:30 am.
Agenda: To review and evaluate contract
proposals.
Place: Chevy Chase Holiday Inn, Chevy
Chase, MD 20815.
Contact Person: Louise P. Corman,
Scientific Review Administrator, Review
Branch, Room 7180, Division of Extramural
Affairs, National Heart, Lung, and Blood
Institute, National Institutes of Health,
Bethesda, MD 20892–7924.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.233, National Center for
Sleep Disorders Research; 93.837, Heart and
Vascular Diseases Research; 93.838, Lung
Diseases Research; 93.839, Blood Diseases
and Resources Research, National Institutes
of Health, HHS)
Dated: June 22, 2001.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 01–16337 Filed 6–28–01; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Heart, Lung, and Blood
Institute; Notice of Closed Meeting
Name of Committee: National Heart, Lung,
and Blood Institute Special Emphasis Panel,
Demonstration and Education Research Grant
Applications (R18s).
Date: July 10–11, 2001.
Time: 12:30 pm to 1 pm.
Agenda: To review and evaluate grant
applications.
Place: Chevy Chase Holiday Inn, Chevy
Chase, MD 20815.
Contact Person: Louise P Corman,
Scientific Review Administrator, Review
Branch, Room 7180, Division of Extramural
Affairs, National Heart, Lung, and Blood
Institute, National Institutes of Health,
Bethesda, MD 20892.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.233, National Center for
Sleep Disorders Research; 93.837, Heart and
Vascular Diseases Research; 93.838, Lung
Diseases Research; 93.839, Blood Diseases
and Resources Research, National Institutes
of Health, HHS)
Dated: June 22, 2001.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 01–16336 Filed 6–28–01; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Heart, Lung, and Blood
Institute; Notice of Closed Meeting
(Catalogue of Federal Domestic Assistance
Program Nos. 93.233, National Center for
Sleep Disorders Research; 93.837, Heart and
Vascular Diseases Research; 93.838, Lung
Diseases Research; 93.839, Blood Diseases
and Resources Research, National Institutes
of Health, HHS)
Dated: June 22, 2001.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 01–16335 Filed 6–28–01; 8:45 am]
BILLING CODE 4140–01–M
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
VerDate 11<MAY>2000
18:18 Jun 28, 2001
Jkt 194001
PO 00000
Frm 00092
Fmt 4703
Sfmt 4703
E:\FR\FM\29JNN1.SGM
pfrm04
PsN: 29JNN1
